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Abstract  
 
Mutations that lead to hyperactivation of Ras signaling are hallmarks of carcinomas. 
However, Ras signaling also mediates cell fate decisions and cellular differentiation 
without causing hyperproliferation during development. It is not known what dictates 
whether Ras signaling drives differentiation vs. proliferation.  Here we show that the 
Hippo pathway is critical for this decision. Loss of Hippo signaling switches Ras 
activation from promoting cellular differentiation to aggressive cellular proliferation. 
Transcriptome analysis combined with genetic tests show that this excessive 
proliferation depends on the synergistic induction of Ras target genes. Using ChIP-
nexus, we find that Hippo signaling keeps Ras target genes in check by directly 
regulating the expression of two key downstream transcription factors of the Ras 
pathway: the ETS-domain transcription factor Pointed and the transcriptional 
repressor Capicua. Our results highlight how independent signaling pathways can 
impinge on each other at the level of transcription factors, thereby providing a safety 
mechanism to keep proliferation in check under normal developmental conditions. 
 
Introduction 
 
The development of cancer usually requires the accumulation of multiple genetic 
aberrations, with most tumors having 2 to 6 driver mutations (Kandoth et al., 2013, 
Tomasetti et al., 2015). Some of the most frequent driver mutations occur in 
components of the Epidermal Growth Factor Receptor (EGFR)-Ras-Raf-MAPK 
pathway, hereafter referred to as the Ras pathway. EGFR is mutated or amplified in 
nearly one-fifth of all cancers tested, and mutations in the downstream effectors 
KRAS and BRAF are found in 22.4% and 18.7% of all cancer samples tested, 
respectively, as tabulated in the Catalogue of Somatic Mutations in Cancer 
(COSMIC) database (Forbes et al., 2015). These cancer-associated mutations cause 
hyperactivation of the Ras pathway and have a major contribution to transformation 
of a normal cell into a cancer cell (Lemmon and Schlessinger, 2010, Burgess, 2008, 
Vakiani and Solit, 2011). However, hyperactivation of Ras signaling by itself is not 
sufficient to cause cellular transformation. Thus, activating mutations in the Ras 
pathway cause only a mild excess in proliferation in different animal models, but can 
lead to aggressive and metastatic tumors in combination with mutations in other 
genes such as p53, the cell polarity proteins Scribbled and Discs-large, or 
components of the JNK and Hedgehog (Hh) signaling pathways (Xia and Land, 
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2007, Pagliarini and Xu, 2003, Wu et al., 2010, Schnidar et al., 2009, Pearson et al., 
2011, Brumby and Richardson, 2003, Chabu et al., 2017, Uhlirova and Bohmann, 
2006). However, the underlying mechanisms leading to excess proliferation in 
response to these combinatorial mutations remain largely unknown. Here, we show 
that mutations in Hippo signaling strongly synergize with activated Ras signaling and 
dissect out the underlying mechanism of this synergistic interaction using genomics, 
genetics and computational approaches. We find that the transcriptional output of 
Ras signaling is under the tight control of the Hippo pathway. Given that p53, Hh, 
Scribbled and Discs-large all modulate Hippo signaling (Colombani et al., 2006, 
Richardson and Portela, 2017, Kagey et al., 2012), our findings also provide a model 
for how these molecules synergize with Ras during tumorigenesis. 
 
The Hippo pathway is known for its key role in controlling organ growth and 
progenitor cell proliferation (Hariharan, 2015, Halder and Johnson, 2011, Pan, 2010, 
Barry and Camargo, 2013). Named after its founding kinase Hippo (Hpo), the 
pathway coordinately regulates cell proliferation and cell death. Cells that lack Hippo 
signaling proliferate faster and are resistant to apoptotic stimuli, a combination that 
leads to dramatic tissue overgrowths in flies and mice. Notably, loss of Hippo 
signaling in the mouse liver leads to tumor formation (Zhou et al., 2009, Song et al., 
2010, Lee et al., 2010, Lu et al., 2010) and YAP, the transcriptional effector of Hippo 
signaling, is an established oncogene in the ovary, lung, liver and breast (Harvey et 
al., 2013, Zanconato et al., 2016).  
 
The components and mechanisms of Hippo signaling are highly conserved in 
animals. At the core of the Hippo pathway is a kinase cascade where in Drosophila 
the Hpo kinase (Mst1/2 in mammals) phosphorylates and activates the Warts kinase 
(Wts, Lats1/2 in mammals). The main substrate of activated Wts/Lats is the 
transcriptional co-activator Yorkie (Yki, YAP/TAZ in mammals), which is retained in 
the cytoplasm upon phosphorylation. In the absence of Hpo pathway activity, Yki 
translocates into the nucleus and binds to the TEAD family transcription factor 
Scalloped (Sd, TEAD1-4 in mammals) and other transcription factors. By default, Sd 
is a repressor, but the binding of Yki converts Sd into an activator and together they 
then drive the expression of pro-survival and proliferation genes, such as cyclin E, 
diap-1 and bantam microRNA (Koontz et al., 2013, Hariharan, 2015). Multiple 
upstream regulators including the FERM domain proteins Merlin (Mer) and Expanded 
(Ex), the atypical cadherins Fat and Dachsous, cell polarity and mechanical forces 
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have been shown to activate the Hpo kinase (Grusche et al., 2010, Piccolo et al., 
2014, Legoff et al., 2013, Mao et al., 2013, Karaman and Halder, 2017). 
 
Here, we studied the effects of combining mutations in the Ras and Hippo pathways. 
Notably, reducing Hippo signaling in cells harboring activating mutations in the Ras 
pathway caused strongly synergistic overgrowth in Drosophila imaginal discs. We 
find that in such discs, the differentiation program is shut down. We investigated the 
molecular basis of this synergy using genomics and show that the Hippo pathway 
acts as a gatekeeper for Ras signaling output by restricting the expression levels of 
its transcriptional targets. This is achieved via direct transcriptional control of the 
transcription factors of the Ras pathway. In Drosophila, MAPK regulates gene 
expression via modulating the protein stability of three transcription factors: the 
repressor Capicua (Cic) and the ETS domain proteins Pointed (Pnt) and Yan (Shilo, 
2014, Jiménez et al., 2012). We show that Cic and Pnt are direct Yki/Sd targets. 
Thus, in healthy cells, Hippo signaling acts as a break that restrains the tumorigenic 
potential of activating mutations in the Ras pathway. Inactivating mutations in the 
Hippo pathway, however, unmask this potential and synergistically promote 
hyperproliferation and tumor development.  
 
Results 
Simultaneous deregulation of Ras and Hippo signaling induces synergistic 
overgrowth 
To study the effects of combinatorial mutations in the Ras and Hippo pathways, we 
simultaneously activated Ras signaling and repressed the Hippo pathway in 
Drosophila imaginal discs, simple epithelial structures that are widely used to 
investigate mechanisms of growth control and tissue patterning. To activate Ras 
signaling, we expressed constitutively active oncogenic versions of EGFR (EGFRtop), 
Ras (RasV12), or Raf (RafGOF) (Queenan et al., 1997, Scholz et al., 1997, Stemerdink 
and Jacobs, 1997, Brand and Perrimon, 1994). To deregulate Hippo signaling, we 
used animals that were homozygous for null mutations in the Hippo pathway 
component expanded (ex) (Hamaratoglu et al., 2006). Loss of ex does not fully 
abolish Hippo pathway activity and ex mutant wing discs showed mild overgrowth 
characteristic for hypomorphic Hippo loss-of-function phenotypes (Fig.1A-B). 
Similarly, overexpression of activated EGFR in a central stripe in wing discs using 
the dpp-Gal4 driver only caused a widening of the expression domain marked by 
GFP co-expression (Fig.1C). Strikingly, however, expressing activated EGFR in ex 
mutants caused massive overgrowth of mutant wing discs (Fig.1D-D’). Double 
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mutant larvae pupated up to two days later than controls when discs continued to 
grow and eventually folded onto themselves. Such cooperative over-proliferation in 
response to EGFR/Ras activation was formerly described in cells that harbor 
mutations in the Hippo pathway components fat (Garoia et al., 2005) and wts 
(Pagliarini and Xu, 2003). Notably, expression of activated Ras or Raf in ex mutants 
caused the same dramatic overgrowth phenotypes (Fig.S1A). Furthermore, the 
enormous overgrowths in the presence of EGFRtop and ex mutants was evident in 
multiple tissues including eye, antenna, wing, leg, and haltere imaginal discs (Fig.1E-
H and not shown). Therefore, activated Ras signaling synergistically interacts with 
deregulated Hippo signaling to drive tissue overgrowth and this interaction is 
independent of the type of imaginal discs.  
 
The synergy between Ras and Hippo signaling occurs via the downstream 
effectors Cic and Yki 
We next investigated at which level of the signal transduction cascades the synergy 
operates. First, we overexpressed EGFR together with Yki, the downstream 
transcriptional co-activator of the Hippo pathway. Again this caused highly synergistic 
overgrowth phenotypes (Fig.S1A), indicating that the synergy operates at the level of 
the downstream transcription effector of the Hippo pathway.  
 
To determine the level of interaction in the Ras pathway, we next tested mutations in 
the Cic transcription factor. Cic is a HMG domain transcriptional repressor that 
mediates the effect of Ras on cell proliferation during imaginal eye disc development 
(Tseng et al., 2007). Cic is a suppressor of cell proliferation in imaginal discs and 
activated MAPK phosphorylates Cic, causing its degradation. Ras signaling is 
required for cell proliferation and cell type specification. Thus, cells with a complete 
loss of Ras signaling, due to mutations in egfr, ras, or raf, do not proliferate and fail to 
differentiate (Fig.2B) (Yang and Baker, 2001, Yang and Baker, 2003). The failure of 
ras mutant cells to proliferate is due to ectopic Cic activity because ras, cic double 
mutant cells proliferate normally (Fig.2C) (Tseng et al., 2007). Despite the strong 
rescue in cell proliferation, removal of Cic does not rescue the photoreceptor 
specification defects of ras mutant cells. Double mutant cells contribute to the adult 
eye, but cannot differentiate into photoreceptor cells (Fig.2C). Therefore, Cic is a 
major effector of Ras signaling in proliferation control (Tseng et al., 2007).  
 
We then analyzed the interaction between loss of Cic and loss of Hippo signaling. 
While deletion of cic alone increased cell proliferation in eye discs only slightly, if at 
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all (Fig.2A), simultaneous deletion of cic together with wts enhanced the wts mutant 
phenotype and triggered massive overgrowth beyond the wts phenotype (Fig.2D-E). 
As previously observed, wts mutant cells occupied the majority of the tissue and led 
to overgrown organs (Justice et al., 1995, Xu et al., 1995), and a few animals made it 
into adults (Fig.2D). However, no adults with cic wts clones were recovered (Fig.2E).  
 
We then induced clones with the pan-eye and wing disc drivers ey-FLP and ubx-FLP 
in combination with the Minute technique to produce imaginal discs that were nearly 
entirely mutant (Fig.3) (Morata and Ripoll, 1975). Eye and wing discs with cic wts 
double mutant clones had dramatic overgrowth phenotypes that caused the discs to 
fold onto themselves (Fig.3A-D). Time course analysis and quantifications showed 
that animals with cic wts double mutant wing discs had extended larval periods by 
about four days similar to animals with wts mutant discs. Mutant cells continued to 
proliferate during this extra time, and cic wts double mutant discs were consistently 
larger than wts discs reaching up to 10 times the normal disc size (Fig.3E-F). 
Importantly, ectopic Yki also synergized with Cic knock-down in causing tissue 
expansion (Fig.S1B-C). Hence, deregulating the Ras and Hippo pathways at the 
level of their downstream transcription factors produced the same highly synergistic 
overgrowths. Altogether, these data show that the synergy between the Hippo and 
Ras pathways is at the level of transcription.  
 
Loss of Wts and Cic synergistically activates Ras target genes 
Because the synergy between the Ras and Hippo pathways is at the level of the 
downstream transcription factors, the two pathways may converge on a set of 
synergistically regulated target genes that are activated only when both pathways are 
deregulated. We therefore performed genome-wide expression analyses (RNA-seq) 
in control, cic and wts single mutant, as well as cic wts double mutant wing discs to 
identify synergistically regulated target genes.  
 
Mutations in wts cause developmental delay and we thus produced gene expression 
profiles by RNA-seq at day 5 in all genotypes and at day 9 in wts single mutant and 
cic wts double mutant wing discs generated using ubx-FLP and a Minute 
chromosome (as shown on Fig.3E). We focused on genes with a minimum average 
expression of 50 counts across all samples and significant upregulation was defined 
as a minimum 1.4-fold increase, with less than 1% false discovery rate (log FC > 0.5 
and adjusted P-value < 0.01). We found that the expression of 350 genes was 
significantly upregulated in day 5 cic wts double mutant wing discs compared to discs 
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with wild-type control clones. Importantly, cell polarity was intact in the day 5 cic wts 
discs (not shown) and hence the transcriptional changes we see at this stage are not 
a consequence of polarity loss. We then classified these genes into four different 
groups, based on day 5 expression levels, using SOTA (self-organizing tree 
algorithm), an unsupervised clustering method (Herrero et al., 2001, Dopazo and 
Carazo, 1997). The first and largest group comprised 295 genes (84% of 
differentially expressed genes) that were up-regulated in wts single and cic wts 
double mutant discs, but not affected in cic mutants (Fig.4A). The upregulation of 
these genes was thus mostly attributed to the wts mutation and we refer to this group 
as the “Wts cluster”. Notably, this cluster contained the known Yki targets kibra, ex, 
wts, dm (a.k.a. Myc) and Ilp8 (a.k.a. Dilp8) (Pan, 2007, Boone et al., 2016, Neto-
Silva et al., 2010, Park et al., 2016, Ziosi et al., 2010), validating the gene expression 
data (Fig.4B). CycE and DIAP1 were also induced in wts and cic wts mutant discs 
but their fold increase was below our cutoff with logFC values of 0.37 and 0.35 
respectively (Fig.4B). The second and smallest cluster contained only 12 genes, 
which were upregulated in cic and in cic wts mutant discs, but were not significantly 
influenced by loss of wts, hence we named it the “Cic cluster” (Fig.4C). The genes in 
this cluster were mostly uncharacterized and non-conserved genes. The third 
“additive” cluster had 17 genes that were mildly upregulated in wts and cic single 
mutants and showed additive upregulation in the double mutant (Fig.4D). These 
genes are potentially shared target genes of Yki and Cic and included sdr (secreted 
decoy of InR), a modulator of insulin signaling (Okamoto et al., 2013); shifted (shf), a 
modulator of Hh signaling (Glise et al., 2005, Gorfinkiel et al., 2005); and the 
ribosomal protein RpL38 (Marygold et al., 2005).  
 
The most interesting fourth cluster had 26 genes that were strongly induced in cic 
wts double mutants but were largely unaffected in cic and wts single mutants; hence 
we coined this set the “synergistic cluster” (Fig.4E). In addition to these genes, closer 
inspection of the wts cluster revealed that 28 of the 295 genes were more than 1.3 
fold higher in the cic wts double mutants compared to wts alone although they were 
not induced or even down-regulated in cic clones. These genes were thus also 
synergistically regulated by Cic and Wts and were reclassified into the synergistic 
group (Fig.4F).  
 
Surprisingly, the most striking feature of the synergistic genes was a strong signature 
of Ras pathway target genes. Synergistically upregulated Ras target genes included 
argos (aos), which encodes a secreted antagonist of Ras signaling (Golembo et al., 
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1996, Schweitzer et al., 1995); sprouty (sty), an intracellular inhibitor of Ras signaling 
(Casci et al., 1999); and Nf1, a negative regulator of Ras activity (Ballester et al., 
1990, Martin et al., 1990, Xu et al., 1990, Buchberg et al., 1990). These genes are 
feedback regulators of Ras signaling in multiple tissues and cell types. Most 
prominently, the major transcriptional activator of the pathway pointed (pnt) (Shilo, 
2014) was also synergistically induced in the double mutants. These data thus show 
that Ras signaling output is strongly upregulated in cic wts double mutant cells, much 
above the levels detected in cic or wts mutant cells. Therefore, simultaneous loss of 
cic and wts resulted in a synergistic hyperactivation of Ras output. 
 
The discovery of 54 genes that were synergistically upregulated in response to 
concomitant loss of wts and cic reveals that the synergistic overgrowth phenotype of 
the double mutant is not a trivial consequence of simultaneous deregulation of two 
unconnected growth control pathways. Rather, the existence of this synergistic gene 
set shows that activation of one or the other pathway is not sufficient to upregulate 
their expression and thus that Cic and Wts act as dominant inhibitors on their 
expression. The discovery of this synergistically deregulated gene set then prompted 
two questions: First, what are the transcription factors that regulate the synergistically 
regulated genes? And second, how does the deregulation of the Hippo pathway 
induce their expression?  
 
iRegulon identifies three key transcription factors that mediate the synergy  
To understand the mechanisms that regulate the transcription of the synergistic 
genes and to elucidate how Ras target genes were hyper-induced in double mutant 
cells, we searched for transcription factor binding sites that were enriched near the 
genes of the four gene clusters using iRegulon, a sequence-based motif discovery 
tool (Janky et al., 2014). iRegulon reverse-engineers a gene regulatory network from 
the expression data by identifying enriched motifs for transcription factors in a given 
set of genes (Janky et al., 2014). We focused our search on the introns and 5kb 
upstream region of each gene. Reassuringly, one of the top motifs (normalized 
enrichment score (NES) of 4.3, see Methods) in the Wts cluster belonged to the Sd 
transcription factor, and high confidence Sd binding sites were detected in 123 of 295 
genes in this cluster and in all known direct Sd target genes (Atkins et al., 2016). The 
very top motif, however, belonged to the AP-1 transcription factors (NES=4.76), 
found enriched near 154 genes, indicating the involvement of JNK signaling. Notably, 
the AP-1 transcription factors, Atf3 and Pdp1, are themselves part of the Wts cluster, 
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suggesting that JNK activation is a downstream effect of Yki activity consistent with 
the recent literature (Ma et al., 2015). 
 
Surprisingly, the Cic cluster was not enriched for Cic binding sites, as only one gene, 
CG32354, had a Cic motif. However, iRegulon analysis on the synergistically 
induced genes (Fig.S2A) identified the Cic binding motif as the top hit with very high 
confidence (NES=6.3), followed by Stat92E (NES=4.3) and Pnt (NES=3.4) motifs 
(Fig.5A). Indeed, the previously identified Cic target genes pnt and aos (Roch et al., 
2002, Jin et al., 2015) were in this synergistic cluster. Therefore, we embarked on to 
determine whether other synergistically regulated genes are also direct Cic targets.  
 
Cic directly regulates synergistically induced genes 
We defined Cic target genes genome-wide using ChIP-nexus (chromatin 
immunoprecipitation experiments with nucleotide resolution through exonuclease, 
unique barcode and single ligation), a robust ChIP-exo protocol that allows high 
resolution mapping of binding sites (He et al., 2015). We used the Cic signal in cic 
wts mutant discs as background. Combining the ChIP-nexus signal with motif 
enrichment to determine high confidence Cic peaks, we identified over 100 regions 
bound by Cic. We then further selected those peaks that were near genes that are 
induced in cic wts discs compared to wild-type. These strict criteria gave us a list of 
19 high-confidence Cic target genes (Fig.S2B). Strikingly, this set contained many 
regulators of the Ras pathway: the Spitz (Spi) ligand, and the negative feedback 
regulators Aos, Sty, Nf1, and Sulfated (Sulf1) (Butchar et al., 2012). Hence, Cic is a 
key factor for feedback regulation of Ras signaling.   
 
Next, we asked which factors might regulate the expression of these 19 Cic target 
genes using iRegulon. As expected, iRegulon identified the Cic motif as the top hit 
(NES=7.3). In addition, regulatory regions of Cic target genes were also enriched for 
Pnt (NES=4.5) and Stat92E (NES=4.4) binding motifs (Fig.5B), similar to the 
predictions for synergistically induced genes. Indeed, seven of the 19 Cic target 
genes were part of the synergistically induced gene set. These were the two known 
Cic targets pnt and aos; three other Ras pathway genes sty, nf1 and sulf1; Leucine-
rich tendon-specific protein (Lrt) and Brinker (Brk), the transcriptional repressor of 
Dpp signaling. Therefore, induction of genes that are normally repressed by Cic is 
the main feature of our synergistic network and at least seven of our synergistic 
target genes are direct Cic targets.  
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The finding that synergistically regulated genes are highly enriched for Cic target 
genes is striking as it shows that the repressor function of Cic on its target genes is 
dependent on the level of Yki activity. Thus, while Cic represses the expression of 
Ras target genes, loss of this break needs to be combined with activation of Yki-Sd 
to strongly induce their expression. This then prompted the question whether the Yki-
Sd complex directly regulates Cic target genes.  
 
Sd and Cic do not compete for DNA binding 
Intriguingly, the consensus DNA-binding sequences of Sd (CATTCC) and Cic 
(CATT(C/G)A) are very similar and differ only at one position. Hence, Sd may directly 
compete with Cic for binding to regulatory sequences. We tested this hypothesis 
using the ChIP-nexus data for Cic and also performed ChIP-nexus for Sd. Combining 
ChIP-nexus signal with motif enrichment identified 800 regions bound by Sd in the 
genome of wing disc cells. Strikingly, we did not find binding sites that were bound by 
both Sd and Cic in wild-type wing discs. We then compared Sd binding between wts 
and cic wts mutant discs to ask whether Sd now occupies more sites. However, we 
did not detect new Sd peaks where Cic normally binds. Therefore, Sd does not 
regulate Cic target genes by competing with Cic for binding the DNA.  
 
We also tested whether Cic can regulate Sd target genes, by searching for Cic peaks 
in their regulatory regions. We did not find any Cic binding in the prominent Yki-Sd 
target genes DIAP1, ex, wts, ft, ds, fj or ilp8. On the other hand, these regulatory 
regions were enriched for Sd motifs and had Sd binding as expected. In agreement 
with these findings, the expression of Yki-Sd target genes were induced at 
comparable levels in wts and in cic wts mutant discs (Fig.4B), supporting the 
conclusion that Cic does not regulate the expression of Yki target genes. Therefore, 
we conclude that Sd and Cic do not affect each other's ability to bind to target DNA in 
vivo and their binding motifs, despite only a single nucleotide difference, are clearly 
distinct. 
 
JAK-STAT signaling and Pnt contribute to the synergistic overgrowth 
iRegulon found no enrichment for Sd binding sites within our synergistic gene set. 
However, in addition to the Cic motif, this gene set was enriched for Pnt and Stat92E 
binding sites. Stat92E is the transcription factor of the JAK-STAT pathway, another 
important pathway in tumorigenesis (Amoyel et al., 2014, Zoranovic et al., 2013). 21 
of our 46 synergistic genes, including Pnt itself, are predicted to be regulated by Pnt, 
Cic and Stat92E together (Fig.5A). More than half of our synergistic genes (27/46) 
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had binding sites for at least 2 out of these 3 factors (Fig.5A). Therefore, we tested 
the importance of Pnt and Stat92E for the synergistic overgrowth. 
 
First, we found that the ligands of the JAK-STAT pathway, the Unpaired cytokines 
Upd1 (a.k.a. os), Upd2 and Upd3 are highly upregulated (2.1; 2.6; 2.4 fold 
respectively) in day 5 wts mutant discs (Fig.5C). Upd levels stayed high at day 9 wts 
discs and were further upregulated in cic wts double mutant discs (3; 6.18; 4.5 fold, 
respectively) (Fig.5C). Hence, having upregulated Upd ligand expression, JAK-STAT 
signaling is likely more active in wts and cic wts mutant cells. JAK-STAT signaling is 
frequently implicated in human cancer and it is commonly induced in Drosophila 
tumor models (Atkins et al., 2016, Davie et al., 2015, Wu et al., 2010). We then 
tested whether JAK-STAT activation is important for the synergistic overgrowth of cic 
wts mutants by expressing an inhibitor of the pathway, Socs36E (Stec et al., 2013), 
in our synergistic background (activated EGFR expression in ex background). Co-
expression of Socs36E efficiently suppressed the overgrowth phenotype in both wing 
and eye discs (Fig.5F-G vs 5D-E). Notably, the expression of the Upd genes is 
regulated by the Yki-Sd complex (Bunker et al., 2015) and we found ChIP-nexus 
peaks and corresponding motifs for both Sd and Cic near the upd genes (Fig.S2C). 
Altogether, these results show that the transcriptional regulation of the Upd genes 
and the activation of JAK-STAT signaling is an important contributor to the synergy 
between the Hippo and Ras pathways.  
 
We then used the same assay to test the contribution of Pnt upregulation to the 
synergistic phenotype. We constructed a stock where pnt-RNAi is under the control 
of the dpp-Gal4 driver. These flies are viable, fertile and only have mild venation 
defects on their wings (not shown), suggesting that Pnt function is only slightly 
reduced but largely intact in this background. However, this mild downregulation of 
Pnt activity was sufficient to prevent the development of full-fledged synergistic 
overgrowth. Discs that expressed pnt-RNAi in addition to activated EGFR in an ex 
mutant background did not display the full-grown synergistic overgrowth phenotype 
(Fig.5H-J). Therefore, high Pnt levels are important for the synergistic overgrowth 
obtained when both Ras and the Hippo pathways are manipulated. 
 
Yki-Sd controls the expression of the Ras pathway transcription factors 
Pointed and Capicua 
Having established that the network predicted by iRegulon is indeed driving the 
synergistic growth, and that Yki-Sd can influence this network via induction of Upd 
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transcription, we asked whether Yki-Sd could also regulate the other nodes of the 
network: Pnt and Cic.  
 
We first had a closer look at the regulation of Pnt. The PntP2 isoform is known to be 
activated by MAPK phosphorylation and drives the expression of PntP1 in eye discs 
(Shwartz et al., 2013). In addition, Cic negatively regulates Pnt expression in 
intestinal stem cells (Jin et al., 2015). To characterize its potential regulation by 
Hippo signaling, we generated antibodies against Pnt, which detected a pattern 
identical to dpERK and complementary to Cic in the wing and eye discs (Fig.6A-B 
and S3A-B). Removal of Cic was sufficient to derepress Pnt expression in wild-type 
and ex mutant cells (Fig.6C-C’ and S3F-F’). Since cic wts mutant clones occupy 
large areas, Pnt was expressed widely and lost all pattern in cic wts discs (Fig.S3G-
G’). These data confirm a tight regulation of Pnt expression by Ras signaling and 
establish Cic as an important regulator of pnt expression in imaginal discs. Direct 
regulation of Pnt by Cic is also strongly supported by our ChIP data. Of the 100 top 
Cic peaks in the genome of wing disc cells, 7 were in the pnt region and 
corresponded to Cic motifs (Fig.6D, Cic ChIP signal is shown in red; Sd ChIP signal 
is shown in blue). Furthermore, the RNA-seq data shows that transcription of pnt is 
induced when the repressor Cic is removed (Fig.5C). Notably, RNA levels of pnt are 
further increased in cic wts double mutant discs, although there is no increase in wts 
single mutants (Fig.5C). In fact, pnt is expressed at lower levels in wts and ex mutant 
discs (Fig.5C and S3E), probably due to higher Cic levels. Therefore, there must be 
another, positive input into pnt expression that depends on Yki-Sd (Fig.5A). Indeed, 
our ChIP-nexus detected a strong Sd peak containing a Sd motif (blue) in the pnt 
gene, which is also enriched for Pnt (green) and Stat92E (purple) binding sites 
(Fig.6D). We conclude that Cic, Yki-Sd, Stat92E, and Pnt itself control pnt 
transcription, and that repression by Cic is dominant over the activating inputs.  
 
Finally, we investigated whether Cic is a Sd target gene. We found multiple Sd ChIP-
nexus peaks with corresponding Sd binding motifs in the cic gene region (Fig.6F). 
However, cic RNA levels, as well as Cic protein levels, were only slightly higher in 
wts mutant wing discs (Fig.5C, 1.1 fold in day 5 and 1.23 fold in day 9 discs). On the 
other hand, Cic accumulation was obvious in eye discs posterior to the 
morphogenetic furrow and in-between the clusters of differentiating photoreceptor 
cells (Fig.6E-E’’), where Cic is normally present at low levels (Fig.S3B). Cic is 
expressed at high levels and uniformly in the wing discs, except for the cells where 
MAPK leads to its degradation (Fig.6A). We thus hypothesized that Yki-Sd are 
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required for the high uniform Cic expression. Indeed, knockdown of Yki in the 
posterior half of wing discs reduced Cic levels (Fig.6G-H’). Hence, induction of Cic 
transcription by Yki-Sd increases the threshold of Ras activity that is required to 
induce its target genes.  
 
Discussion 
The main conclusion from our study is that Hippo activity determines the outcome of 
Ras signaling. In our model, combined action of Hippo signaling and the repressor 
Cic prevents excessive proliferation and allows differentiation by keeping a set of key 
target genes off (Fig.7). Cic suppresses many of these genes directly and Hippo 
signaling prevents their full activation at least partially by keeping both JAK/STAT 
activity and Pnt levels low. This model is based on three key observations. First, we 
found that activated Ras signaling has different outcomes in wild-type discs vs ex 
mutant discs. While hyperactivation of Ras signaling in a wild-type disc promotes 
cellular differentiation, Ras activation combined with loss of ex drives aggressive 
hyperproliferation. Second, we defined a set of synergistic genes that were strongly 
induced only when the repressor Cic was removed and Yki was simultaneously 
activated. These genes were predicted to be regulated by Cic, Pnt, and Stat92E. 
Indeed, we confirmed that high Pnt levels and JAK/STAT activity contributed to the 
synergistic overgrowth phenotype. Lastly, we found that the Hippo pathway 
transcription factor Sd directly regulates the expression of the JAK/STAT ligands and 
the Ras signaling transcription factors Cic and Pnt. When Hippo signaling and Cic 
are simultaneously inhibited, the synergistic genes and the Yki targets are expressed 
at high levels, paving the way to cellular transformation. 
 
We defined a small set of direct Cic target genes in wing discs. Identification of many 
feedback regulators of Ras signaling among direct Cic targets emphasizes the 
central role of this protein in controlling Ras output despite the weak phenotypic 
consequences of its removal. Notably, Cic expression is complementary to that of the 
other two transcription factors of Ras signaling, Pnt and Yan (Fig.S3A-C). Indeed, 
Cic controls Pnt transcription in multiple tissues, but our RNA-seq and ChIP-nexus 
data on wing discs suggests Cic does not regulate Yan.      
 
Our data reveal a fundamental interaction between the Ras and Hippo pathways 
occurring at the level of their downstream transcription factors. Other points of 
crosstalk have been reported in the literature. Most prominently, MAPK was 
suggested to phosphorylate and activate the LIM domain protein Ajuba, a negative 
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regulator of the Wts kinase (Reddy and Irvine, 2013). Similarly, oncogenic Ras can 
induce Yap activation (Reddy and Irvine, 2013, Hong et al., 2014). We confirmed that 
overexpression of constitutively active EGFR or Ras induced the expression of the 
Yki regulated reporter gene ex-lacZ (Fig.S4A-B). Surprisingly however, this was not a 
general effect and was dependent on the position of the clone. Thus the effect of Ras 
hyperactivation on the Hippo pathway depends on the fate of a cell. Likewise, only a 
fraction of patients with activating mutations in Ras have elevated YAP levels 
paralleling the context dependency that we observed in discs (Lin et al., 2015). 
Unlike activation of Ras, loss of cic did not induce Yki activity. Notably, this was true 
in a wild-type background and in ex and wts mutant backgrounds in which loss of cic 
caused synergistic overgrowth (Fig.S4C-F). Two conclusions follow from these 
results. First, Ras signaling crosses over to the Hippo pathway only upstream of Cic, 
consistent with the model that MAPK regulates the activity of Ajuba (Reddy and 
Irvine, 2013). Second, the synergy between Ras and Hippo signaling cannot depend 
on the regulation of Hippo pathway activity by Ras signaling because loss of cic 
synergized with loss of wts in growth control even though Cic does not affect Yki 
activity. Thus, the synergy between the Hippo and Ras pathways is not due to a 
general activation of Yki in response to loss of Cic. Rather, we show that the synergy 
is due to hyperactivation of the Ras signaling output, which is under direct Yki-Sd 
control. Therefore, there are at least two points of crosstalk between the two 
pathways: one upstream of Cic via Ajuba and another at the level of transcription 
factors as described here. 
 
Strikingly, in the cic wts double mutant discs, the activities of the other major 
developmental pathways are reduced: Dpp, Hh, N and Wg signaling activity readouts 
are expressed at low levels, suggesting a block in the differentiation program 
(Fig.S5A). Activation of two key Cic target genes, Sulf1 and Brk, are likely to account 
for this observation. Sulf1 encodes an extracellular protein from the endosulfatase 
family that regulates the amount and pattern of sulfate groups on heparan sulfate 
proteoglycans (HSPGs). HSPGs in turn play major roles on morphogen distribution 
and patterning (Yan and Lin, 2009). Accordingly, Sulf1 was linked to dampening the 
activity of Wg and Hh signaling pathways (Kleinschmit et al., 2013, You et al., 2011, 
Wojcinski et al., 2011). Brk, the default repressor of Dpp signaling (Affolter and 
Basler, 2007), is also a direct Cic target and is highly induced in cic wts cells. As a 
result of the action of Sulf1, Brk and potentially others, we see a block in 
differentiation signature in cic wts double mutant cells (Fig.S5A). In these cells, the 
readout for Ras signaling is highly upregulated, and simultaneously Dpp, N, Wg and 
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Hh pathways are downregulated. Consequently, cic wts cells lose their differentiation 
potential and proliferate aggressively (Fig.S5B). Therefore, combined mutations in 
Hippo and Ras pathways are especially dangerous as both breaks that dampen the 
transformation potential of a cell are removed (Fig.7). We show that Cic and its 
targets are central to Ras driven tumorigenesis and the choice between 
differentiation vs proliferation. Activation of Yki/YAP along with Cic degradation 
switches the response of a cell from differentiation to proliferation by allowing full 
activation of Cic targets. 
 
Our analysis of the mechanism by which Hippo and Ras synergise to produce 
massive tissue overproliferation in flies is likely to be relevant to tumour formation in 
verterbrates. Recent work indicates that if activation of Ras or Raf is coupled with 
amplification of the YAP region, the resulting carcinomas are more aggressive and 
resistant to MEK and Raf inhibitors (Lin et al., 2015). It has also been shown that 
mutations in Nf2, an upstream regulator of Hippo, cooperate with activating Ras 
mutations in a mouse model of thyroid cancer and that co-expression of Ras and 
YAP lead to brain tumor formation in zebrafish (Garcia-Rendueles et al., 2015, 
Mayrhofer et al., 2017). These findings bring forth the conservation of tumor 
suppressor pathway structures and underline the need for a mechanistic 
understanding such as the one exposed here. Our results argue that the 
transcriptional output of Ras signaling is under Hippo control and that Cic targets can 
only be fully activated when Yki/YAP is active (Fig.7). Requiring Yki activation and 
simultaneous removal of Cic for full induction, such “synergy genes” may represent 
attractive drug targets.  
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Figure Legends: 
Figure 1: Activated EGFR can induce either differentiation or proliferation.  
(A-D’) Wing and (E-H) eye-antennal imaginal discs from late third instar larvae 
expressing the indicated UAS transgenes with the dpp-Gal4 driver. (A and E’) The 
expression pattern of dpp-Gal4 (green). ex-lacZ is shown in red (A-D’), Ci antibody 
marks the MF (red in F-H) and photoreceptor cells are labeled with ELAV antibodies 
(green in E-H). (B) Homozygous ex mutant discs are slightly overgrown and (F) have 
defects in the movement of the morphogenetic furrow (MF) in the eye. (C) 
Expression of activated EGFR (EGFRtop) in the dpp stripe (green) leads to expansion 
of this region and (G) induces ectopic photoreceptor differentiation. (D and H) The 
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same construct (EGFRtop) induces massive overgrowth in the absence of ex. All 
images are shown at the same scale. Scale bar in (D) is 50 µm. Genotypes: 
A&E: w; exe1/+; dpp-Gal4, UAS-GFPnls/+ 
B&F: w; exe1/exAP50; dpp-Gal4, UAS-GFPnls/+ 
C&G: w; dpp-Gal4, UAS-GFPnls/ UAS-EGFRtop 
D-D’&H: w; exe1/exAP50; dpp-Gal4, UAS-GFPnls/ UAS-EGFRtop 
 
Figure 2: The synergy between the two pathways is at the level of 
transcriptional regulation. 
Third instar eye-antennal imaginal discs (top rows) and male fly heads (bottom row) 
carrying eyflp (expressed only in the head) induced clones of indicated genotypes. 
Mutant clones are marked by the absence of GFP (green in top, gray in middle 
panel) or lack of mini-w+ expression (red in bottom panel). (A) cicQ474X mutant cells 
occupy roughly half the tissue and have no effect on photoreceptor differentiation 
marked by ELAV (red), (B) rasDC408 mutant clones are small in the larval eye and do 
not contribute to the adult tissue, (C) further deletion of cic rescues the proliferation 
but not the differentiation defects of rasDC408 mutant cells, (D) wts149 mutant cells 
over-proliferate and (E) cicQ474X wts149 double mutant cells induce overgrowth and 
many folds in the tissue. The eye field is very small. All discs are from day 5 larvae 
and are shown at the same magnification. Scale bar in (A) is 100 µm. Genotypes: 
A) y w eyflp / y w; FRT82B ubiGFPnls / FRT82B cicQ474X 
B) y w eyflp / y w; FRT82B ubiGFPnls / FRT82B rasDC408 
C) y w eyflp / y w; FRT82B ubiGFPnls / FRT82B rasDC408 cicQ474X 
D) y w eyflp / y w; FRT82B ubiGFPnls / FRT82B wts149 
E) y w eyflp / y w; FRT82B ubiGFPnls / FRT82B cicQ474X wts149 
 
Figure 3: Combined mutations in cic and wts induce tremendous overgrowth 
and delayed pupation.  
(A-B) Control wing and eye discs at the end of larval development. (C-D) Eye and 
wing discs with cicQ474X wts149 double mutant cells in a Minute background. (E) Time 
course analysis (day 3, 4, 5, 6 and 9) of wing discs with indicated genotypes. 
Mutations in wts lead to delayed pupation. (F) ubx-FLP, cic wts discs can grow up to 
10 times bigger than a full-grown wild-type wing disc. The graph shows wing area 
quantification at different time points (n= 3-5 discs per time point per genotype) and 
in fact underestimates the size of cic wts double mutant discs as they form many 
folds and are on average twice as thick as wts discs. All images are at the same 
magnification. The scale bars in (A) and (E) are 200 µm. Genotypes: 
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A-B) y w; FRT82B M(3) ubiGFPnls / FRT82B cicQ474X wts149 
C) y w eyflp / y w; FRT82B M(3) ubiGFPnls / FRT82B cicQ474X wts149 
D) y ubxflp / y w; FRT82B M(3) ubiGFPnls / FRT82B cicQ474X wts149 
E-F) wt: y ubxflp / y w; FRT82B M(3) ubiGFPnls / FRT82B  
       wts: y ubxflp / y w; FRT82B M(3) ubiGFPnls / FRT82B wts149 
       cic: y ubxflp / y w; FRT82B M(3) ubiGFPnls / FRT82B cicQ474X 
       cic wts: y ubxflp / y w; FRT82B M(3) ubiGFPnls / FRT82B cicQ474X wts149 
 
Figure 4: RNA-sequencing reveals synergistically regulated genes. 
Self Organizing Tree Algorithm (SOTA) found 4 clusters among the 350 upregulated 
genes in day 5 cic wts discs compared to the control discs. Row normalized heat-
maps of (A) Wts cluster, (B) known Yki target genes from the Wts cluster. Dilp8 is 
shown separately as it is most upregulated (28-folds in wts discs) and disrupts the 
visualization of the data when grouped with the other genes. (C) Cic cluster, (D) 
additive cluster, (E) synergistic cluster and (F) 28 genes from the Wts cluster that are 
further upregulated in cic wts discs (1,3 folds or more). Green bars represent 
average expression levels.  
 
Figure 5: Pnt and STAT are predicted key regulators of the synergistic genes 
and are required for the synergistic overgrowth. 
(A) iRegulon predicts that three factors, Cic, Pnt and Stat92E regulate the 
synergistically induced genes. The heat-maps of these 46 synergistic genes are 
shown in Suppl.Fig.2A. 8 genes whose expression did not stay elevated at day 9 cic 
wts discs were removed from the group as they are unlikely to drive the synergistic 
phenotype.  (B) iRegulon analysis on Cic target genes returns the same network as 
shown in panel A. The heat-maps of these 19 direct Cic target genes are shown in 
Suppl.Fig.2B. (C) Heat-map showing the expression levels of JAK-STAT ligands 
Upds and the transcription factors of Ras signaling, Pnt and Cic in different 
genotypes and time-points. (D-J) 7-day old wing (top) and eye-antennal (bottom) 
imaginal discs of indicated genotypes. UAS driven GFP (green) marks the 
expression domain of the dpp-Gal4 driver. Nuclei are shown in red marked by DAPI 
(D-G) or ex-lacZ expression (I-J). (H) Quantification of the wing disc areas with our 
synergistic combination (activated EGFR expression in ex mutant background (dark 
gray)) and upon additional knock-down of pnt (light gray) at different time points. We 
measured at least 6 discs per genotype. For dpp>EGFRtop in ex; day 5, n=11; day 6, 
n=10; day 7, n=9. For dpp>EGFRtop + pnt-RNAi in ex; day 5, n=6; day 6, n=10; day 7, 
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n=9.  All images are shown at the same scale. The scale bar in (F) is 100 µm. 
Genotypes:  
D-E) y w; FRT40A exAP50 / FRT40A exe1; UAS-EGFRtop / dpp-Gal4, UAS-GFP  
F-G) y w; FRT40A exAP50 UAS-SOCS-36E / FRT40A exe1; UAS-EGFRtop / dpp-Gal4, 
UAS-GFP  
I-J) y w; FRT40A exAP50 / FRT40A exe1; UAS-EGFRtop / dpp-Gal4, UAS-GFP, UAS-
pnt-RNAi (UAS-pnt-RNAi is BL31936) 
 
Figure 6: Pointed and Cic are direct Yki-Sd targets. 
(A-B) Cic and Pnt expression patterns, detected by antibody stainings, in late third 
instar wing discs. (C-C’) Pnt is derepressed in cic mutant clones. (D,F) ChIP-nexus 
tracks in pnt (D) and cic (F) genomic regions obtained by overlaying tracks from 
experimental triplicates. Blue and red tracks correspond to Sd and Cic ChIP data, 
respectively. Predicted binding motifs for Cic (red), Sd (blue), Pnt (green) and 
Stat92E (purple) are shown above the tracks. (E-E’’) Cic (red in E and E’’, gray in E’) 
and ELAV (blue in E’’) antibody staining in discs with wts149 mutant clones marked by 
the absence of GFP (green in E) is shown. Cic protein accumulates in 
interommatidial cells. (G-H’) Knocking down yki in the posterior compartment leads to 
a reduction in the compartment size and Cic levels. Hence high, uniform Cic levels 
require Yki input. The scale bars in C’, E and H’ are 100 µm. 
Genotypes: 
C) y w hsflp / y w; FRT82B ubiGFPnls / FRT82B cicQ474X 
E) y w hsflp / y w; FRT82B ubiGFPnls / FRT82B wts149 
G) y w ; en-Gal4 / + 
H) y w ; en-Gal4 / + ; UAS-Yki-RNAi / + 
 
Figure 7: Model of the transcriptional interaction between the Hippo and Ras 
pathways. 
The Hippo pathway effectors Yki-Sd regulate the expression of the Pnt and Cic 
transcription factors of the Ras pathway. The induction of Pnt regulates the sensitivity 
of a cell to Ras signaling, while the induction of Cic increases the threshold required 
for productive output. As a result, Cic target genes and synergy are only fully 
activated when Cic is removed and Yki is simultaneously activated. Thus, the activity 
of the Hippo pathway together with the repressor Cic provide parallel breaks that limit 
Ras signaling output and prevent hyperproliferation and cellular transformation. Blue 
highlights the interactions revealed in this study. 
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Figure S1: Different combinations of Hippo loss and Ras gain-of-function 
induce synergistic overgrowth.  
(A) Regardless of which level of signaling the two pathways are modulated, the 
synergistic overgrowth is observed. Photoreceptors are marked by ELAV staining in 
blue in all panels. The green signal in the middle and the right panel shows the GFP 
expression under dpp-Gal4. The scale bar is 50uM. Genotypes:  
Left) y w; FRT40A exBQ / FRT40A exe1; UAS-RasV12 / dpp-Gal4, UAS-GFP  
Middle) y w; FRT40A exBQ / FRT40A exe1; UAS-RafGOF / dpp-Gal4, UAS-GFP 
Right) y w; UAS-EGFRtop / +; UAS-Yki / dpp-Gal4, UAS-GFP 
(B-C) Yki overexpression in combination with cic knock-down induces synergistic 
overgrowth. Representative discs of indicated genotypes (B) and quantification of the 
GFP-positive areas as a percentage of the whole disc area are shown (C). Error bars 
represent standard deviation. Discs where cic is knocked down are slightly smaller 
(86% of normal size) with a slightly wider Ptc stripe. In discs where Yki is 
overexpressed, the Ptc stripe occupies more than a quarter of the whole disc. 
Additional cic knock-down further expands the Ptc stripe which now occupies a third 
of the disc. All discs shown are from day 5. Ptc> Yki + cic-RNAi larvae have 
extended larval life by an additional 2 days, but the discs do not further grow. 
Anterior is to the left and the scale bar is 100uM. 
Genotypes:  
ptc> GFP : y w; ptc-Gal4, UAS-GFP / CyO 
ptc> cic-RNAi : y w; ptc-Gal4, UAS-GFP / UAS-cic-RNAi  (VDRC line 103805) 
ptc> Yki : y w; ptc-Gal4, UAS-GFP / + ; UAS-Yki / + 
ptc> Yki + cic-RNAi : y w; ptc-Gal4, UAS-GFP / UAS-cic-RNAi ; UAS-Yki / + 
 
Figure S2: Heatmaps for synergistic and Cic target genes. Upd transcription is 
under Sd and Cic control. 
Row normalized heat-maps showing expression profiles of synergistically induced 
genes (A) and direct Cic target genes (B) in day 5 discs of indicated genotypes. (C) 
ChIP-nexus peaks (Sd in blue and Cic in red) and motifs (Sd in blue and Cic in red) 
in the Upd region suggest direct binding of Cic and Sd. 
 
Figure S3: Expression patterns and regulation of Pnt and Yan. 
(A) Pnt and Yan are expressed posterior to the morphogenetic furrow in the eye 
discs. (B) Cic expression pattern is complementary to that of Pnt and Yan in eye 
discs. (C) Yan protein is not detected in wing discs. (D) Pnt antibody staining (gray) 
reflects the Ras activity pattern in a third instar wing imaginal disc. (E) Pnt pattern is 
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weaker in an ex disc likely due to higher Cic levels. (F-F’) Pnt is deprepressed (gray 
F, red in F’) in cic mutant cells marked by the absence of GFP (green in F’) in an ex 
disc. (G-G’) Pnt protein levels (gray G, red in G’) are highly elevated in cic wts mutant 
cells marked by the absence of GFP and the pattern is lost. All images are shown at 
the same scale. Genotypes:  
E) y w / w; FRT40A exe1/ FRT40A exAP50 
F) y w hsflp / w; FRT40A exe1/ FRT40A exAP50; FRT82B ubiGFP/ FRT82B cicQ474X  
G) y w hsflp / y w; FRT82B ubiGFPnls / FRT82B cicQ474X wts149 
 
Figure S4: Ras regulates Yki activity, but Cic does not.  
Late third instar imaginal discs that carry (A) EGFRtop or (B) Ras overexpression 
clones marked by GFP co-expression in green and stained with ß-gal antibodies to 
reveal ex-lacZ expression in red (gray in A’ and B’). Within the pouch region, most 
clones of cells with activated EGFR/Ras signaling showed a cell autonomous 
upregulation of ex-lacZ expression (arrows). On the other hand, clones outside the 
pouch area (arrowheads) had either no effect or only boundary effects on ex-lacZ 
levels. (C) cic mutant clones marked by lack of GFP expression do not modulate ex-
lacZ expression (red in C, gray in C’). (D) cic mutant clones overgrow and form folds 
(arrowheads) in exe1/exAP50 mutant background, but do not affect ex-lacZ expression 
(red in D, gray in D’). (E-F) Ex protein levels are not affected by loss of cic even in a 
wts mutant disc where they overgrow and display synergy. All scale bars are 100u. 
Full genotypes: 
A) y w hsflp / w; FRT40A exe1/+; UAS-EGFRtop/ act < CD2 < Gal4, UAS-GFP  
B) y w hsflp / w; FRT40A exe1/+; UAS-Ras / act < CD2 < Gal4, UAS-GFP  
C) y w hsflp / w; FRT40A exe1/+; FRT82B ubiGFP/ FRT82B cicQ474X 
D) y w hsflp / w; FRT40A exe1/ FRT40A exAP50; FRT82B ubiGFP/ FRT82B cicQ474X  
E) y w hsflp / w; FRT82B wtsP2 ubiGFP/ FRT82B wts149 
F) y w hsflp / w; FRT82B wtsP2 ubiGFP/ FRT82B cicQ474X wts149 
 
Figure S5: The differentiation program is shut down in cic wts mutant cells. 
(A) Row normalized heat-map showing expression profiles of components and target 
genes for developmental pathways in day 5 discs of indicated genotypes. Pathway 
readouts for Dpp, Notch, Wg and Hh signaling are down regulated in cic wts mutant 
discs. (B) Eye discs from indicated genotypes and ages. Similar to Figure 2, but the 
discs are allowed to grow to their maximum potential. wts mutant cells (marked by 
the absence of GFP in green) can differentiate into photoreceptors (red), but are 
positioned further apart from each other due to the increased number of 
22	  	  
interommatidial cells. Photoreceptor rosettes are often incomplete in cic wts mutant 
areas. The scale bar in (B) is 50 µm. Genotypes: 
wt: y w eyflp / y w; FRT82B ubiGFPnls / FRT82B  
wts: y w eyflp / y w; FRT82B ubiGFPnls / FRT82B wts149 
cicwts: y w eyflp / y w; FRT82B ubiGFPnls / FRT82B cicQ474X wts149 
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STAR Methods: 
CONTACT FOR REAGENT AND RESOURCE SHARING  
Requests for resources and reagents should be directed to Fisun Hamaratoglu 
(fisun.hamaratoglu@unil.ch)  
EXPERIMENTAL MODEL AND SUBJECT DETAILS  
Drosophila melanogaster were grown on standard fly medium and kept in 26°C 
incubators.  
METHOD DETAILS  
Immunohistochemistry 
Standard protocols were followed for immunohistochemistry (as detailed in 
(Hamaratoglu et al., 2011)). Antibodies used were: m-β-gal (1:2000, Promega), r-
ELAV (1:1500, DSHB-7E8A10), m-Yan (1:10, DSHB-8B12H9), r-Ci (1:150, Robert A. 
Holmgren), rb-Pnt (1:2000), m-dp-ERK (1:5000, Benny Shilo), gp-Cic (1:300, Iswar 
Hariharan).  
 
Antibody production 
Antibodies against Pnt and Cic were produced by GenScript.  They were antigen 
affinity purified and resuspended in PBS pH 7.4 / 0.02% sodium azide at the 
following concentrations: anti-rabbit-Pnt = 2.622 mg/ml, anti-rabbit-Cic = 1.715 
mg/ml. Pnt C-term half (last 298 aas), that is common to all isoforms, was used as an 
epitope and the antibody recognizes overexpressed Pnt-P1 and Pnt-P2. For Cic, a 
C-term small peptide (NDSDMDDTPFDYRK) was used to generate a peptide 
antibody. 
 
RNA-seq sample preparation and sequencing 
Wing discs were collected from 12-35 larvae under sterile conditions and 
immediately lysed. Genotypes used were: wt, day 5 (y w ubxflp/ y w; FRT82B M(3) 
ubiGFP/ FRT 82B), cic, day 5 (y w ubxflp/ y w; FRT82B M(3) ubiGFP/ FRT 82B 
cicQ474X), wts, day 5 and day 9 (y w ubxflp/ y w; FRT82B M(3) ubiGFP/ FRT 82B 
wts149), cic wts, day 5 and day 9 (y w ubxflp/ y w; FRT82B M(3) ubiGFP/ FRT 82B 
cicQ474X wts149). RNA extraction was done using Ambion RNAqueous Micro kit. 500ng 
total RNA and Illumina TruSeq mRNA Library Prep reagents were used according to 
the protocol recommended by the manufacturer for library preparation and the 
sequencing was done using Illumina HiSeq2500. 
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Isolation of chromatin from imaginal discs 
We used larvae of following genotypes: wild-type control (y w ubxflp/ y w; FRT82B 
M(3) ubiGFP/ FRT 82B), 500 wing discs/ sample; wts mutant discs from day9 giant 
larvae (y w ubxflp/ y w; FRT82B M(3) ubiGFP/ FRT 82B wts149), 100 wing discs/ 
sample; cic wts mutant discs from day9 giant larvae (y w ubxflp/ y w; FRT82B M(3) 
ubiGFP/ FRT 82B cicQ474X wts149) , 100 wing discs/ sample. 
 
Third instar larvae were dissected in cold PBS and imaginal disc complexes (anterior 
one third of the larvae after removing the fat body and salivary glands) were fixed in 
1 ml fixation buffer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
[HEPES], pH 7.5; 1 mM ethylenediaminetetraacetic acid [EDTA]; 0.5 mM ethylene 
glycol tetraacetic acid [EGTA]; 100 mM NaCl; 2% formaldehyde) for 30 min at room 
temperature. Fixed disc complexes were washed 3x fast and 2x 20 minutes with 
PBST (PBS, pH 7.4; 0.1% Triton X-100; 0.1% Tween-20), and were stored at 4°C 
until enough discs were obtained. 100-500 wing discs were dissected away from the 
cuticle and resuspended in buffer A2 (15 mM HEPES, pH 7.5; 140 mM NaCl; 1 mM 
EDTA; 0.5 mM EGTA; 1% Triton X-100; 0.1% sodium deoxycholate; 0.1 % sodium 
dodecyl sulfate [SDS]; 0.5 % N-lauroylsarcosine; 1× Roche complete protease 
inhibitor cocktail, cat. no. 5056489001). Tubes were flash frozen in liquid nitrogen 
and stored at -80°C. Imaginal discs were pooled to reach 500 wt discs (or 100 
mutant), and sonication was performed in a Bioruptor sonicator for 5 min (30 s on/off 
cycle at the “high” setting) in buffer A2. Following centrifugation (16,000 × g; 10 min 
at 4 °C), the supernatant containing soluble chromatin was transferred to fresh tubes, 
and used for ChIP-nexus. 
 
ChIP-nexus 
20 µg antibody (rb-Sd (Ikmi et al., 2014) or rb-Cic) was incubated with Protein A and 
Protein G beads for 6 hours. Chromatin isolated from 500 wild-type and 100 mutant 
imaginal discs were added to antibody coated beads and incubated overnight at 4 °C 
with end to end rotation in a 1ml volume. ChIP-nexus digestion and library 
preparation was performed as published (He et al., 2015), with the following 
modifications. To repair the DNA ends, NEB Next End Repair Module (NEB#E6050) 
was used, and reactions were set up in a 50µl volume at 20°C for 1h in thermomixer 
with gentle mixing. Beads were washed as described previously. The dA tailing 
reactions were set up in a 50µl final volume, incubated for 30 minutes at 37°C using 
the NEBNext dA-Tailing Module (NEB#E6053). The PCR amplification of nexus 
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library was performed using the NEB Next High-Fidelity 2X PCR Master Mix 
(NEB#M0541). All the samples were sequenced with Illumina NextSeq 500. 
QUANTIFICATION AND STATISTICAL ANALYSIS  
iRegulon Normalized Enrichment Scores (NES): 
For a certain gene set as input, the enrichment for each motif (9713 unique PWMs) is 
determined by the Area Under the Recovery Curve (AUC) of the cumulative recovery 
curve, along the whole-genome ranking. A Normalized Enrichment Score (NES) is 
computed as the AUC value of the motif minus the mean of all AUCs for all motifs 
and divided by the standard deviation of all AUCs. This is very similar to a z-score, 
and a NES score of 3 corresponds to an FDR (false discovery rate) of 0.03 to 0.09. A 
high NES for a certain motif indicates that this motif is significantly overrepresented 
in the immediate regulatory space (5kb upstream and all introns) of the genes from 
the input set (Janky et al., 2014).  
 
RNA-seq analysis 
Raw reads were cleaned for adapter sequences using fastq-mcf. Cleaned reads 
were mapped on Drosophila melanogaster FlyBase release r6.03 using TopHat2 
(Kim et al., 2013) (Bowtie2/2.2.1-intel-2014a). Htseq-count (Anders et al., 2015) 
(HTSeq/0.6.1p1-foss-2014a-Python-2.7.6) was used to assign reads to genes using 
the dmel-all-r6.03.gff template. The raw counts matrix (6 conditions each with 3 
biological replicates) was further processed and size factor was normalized in R. The 
list of 350 upregulated genes in cic wts double mutants vs wild type controls was 
obtained using DESeq2 (Love et al., 2014) (differential analysis with 3 replicates, 
cutoff; average expression > 50, logFC > 0.5 and adjusted P-value < 0.01). These 
350 genes were subdivided into four groups, based on their normalized expression 
values (log2 transformed) in the day_5 samples, using an unsupervised clustering 
method (Self Organizing Tree Algorithm, standard parameters in MeV) (Saeed et al., 
2003). Genes from wts cluster whose expression increased more than 1.3 folds from 
wts to cic wts were added to the synergetic cluster. The final set of 46 synergistic 
genes was obtained by filtering out genes whose expression dropped below wild type 
levels in cic wts day_9. Motif enrichment analysis was carried out on each gene set 
using iRegulon v1.4 (Janky et al., 2014), (plugin for Cytoscape) using a library of 
9713 PWMs, taking the full transcript and 5kb upstream of each gene into account. 
Expression heat-maps were generated with the NMF package in R (Gaujoux and 
Seoighe, 2010), using log2 normalized counts and these options: scale="row", 
Rowv=F ,Colv=NA, annRow=medianexp.  
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ChIP-nexus analysis 
Mapped bam files and bigwig files were generated as described from the sequenced 
reads (He et al., 2015). Scalloped peaks were called on the (unclipped) mapped 
reads, using the MACS2 software suite (Feng et al., 2011) (macs2 callpeak -t 
sd_genotype.bam -g dm -n sd_genotype.macs2  --keep-dup all  --call-summits). 
ChIP peaks with sufficient reads (fold change > 10) were retained for further analysis. 
Cic peaks were called on the (unclipped) mapped reads, using Cic-ChIP in cic wts 
mutants samples as control (macs2 callpeak -t cic_genotype.bam -g dm -n 
cic_genotype.macs2  --bdg --nomodel -c cic_cic.wts.bam). Using the negative 
controls (Cic pulldown in cic wts discs) removed most of the noise, allowing us to use 
all the called peaks for further analysis. The retained ChIP peaks were used as input 
sets for i-cisTarget (Imrichová et al., 2015), a tool that identifies significantly enriched 
motifs in a set of (ChIP) regions. Directly bound regions were defined as those 
regions that had their respective transcription factor DNA binding motifs significantly 
enriched. 
DATA AND SOFTWARE AVAILABILITY  
RNA-seq and ChIP-nexus datasets have been deposited to NCBI's Gene Expression 
Omnibus. They are accessible through GEO Series accession number GSE96868. 
ADDITIONAL RESOURCES  
iRegulon: http://iregulon.aertslab.org 
i-cisTarget: https://gbiomed.kuleuven.be/apps/lcb/i-cisTarget/ 
ChIP-nexus Protocol: 
http://research.stowers.org/zeitlingerlab/documents/150709ChIP-
nexusProtocol_000.pdf 
 












